Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

Lebbe, Celeste; Meyer, Nicolas; Mortier, Laurent; Marquez-Rodas, Ivan; Robert, Caroline; Rutkowski, Piotr; Menzies, Alexander M.; Eigentler, Thomas; Ascierto, Paolo A.; Smylie, Michael; Schadendorf, Dirk; Ajaz, Mazhar; Svane, Inge Marie; Gonzalez, Rene; Rollin, Linda; Lord-Bessen, Jennifer; Saci, Abdel; Grigoryeva, Elena; Pigozzo, Jacopo

dc.contributor.author	Eigentler, Thomas
dc.date.accessioned	2020-05-14T13:44:47Z
dc.date.available	2020-05-14T13:44:47Z
dc.date.issued	2019
dc.identifier.issn	1527-7755
dc.identifier.uri	http://hdl.handle.net/10900/100690
dc.language.iso	en	en
dc.publisher	Amer Soc Clinical Oncology	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.18.01998	de_DE
dc.subject.ddc	610	de_DE
dc.title	Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_01738
utue.publikation.seiten	867-	de_DE
utue.personen.roh	Lebbe, Celeste
utue.personen.roh	Meyer, Nicolas
utue.personen.roh	Mortier, Laurent
utue.personen.roh	Marquez-Rodas, Ivan
utue.personen.roh	Robert, Caroline
utue.personen.roh	Rutkowski, Piotr
utue.personen.roh	Menzies, Alexander M.
utue.personen.roh	Eigentler, Thomas
utue.personen.roh	Ascierto, Paolo A.
utue.personen.roh	Smylie, Michael
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Ajaz, Mazhar
utue.personen.roh	Svane, Inge Marie
utue.personen.roh	Gonzalez, Rene
utue.personen.roh	Rollin, Linda
utue.personen.roh	Lord-Bessen, Jennifer
utue.personen.roh	Saci, Abdel
utue.personen.roh	Grigoryeva, Elena
utue.personen.roh	Pigozzo, Jacopo
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	37	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE